Q2 2026 recurring EPS was $0.87, in line with guidance, but GAAP EPS fell due to non-recurring charges. The Aquarion sale generated $1.7B in cash, supporting debt reduction and credit metrics. Revised 2026 EPS guidance is $4.57–$4.72, with long-term growth targets reaffirmed.Original document: Ever…
Q2 2026 recurring EPS was $0.87, in line with guidance, but GAAP EPS fell due to non-recurring charges. The Aquarion sale generated $1.7B in cash, supporting debt reduction and credit metrics. Revised 2026 EPS guidance is $4.57–$4.72, with long-term growth targets reaffirmed.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.